a renewed push to get prescribers to avoid ORAL diclofenac (Cataflam, Voltaren, etc) for treating inflammation and pain

You'll see a renewed push to get prescribers to avoid ORAL diclofenac (Cataflam, Voltaren, etc) for treating inflammation and pain.

That's because diclofenac increases the risk of heart attacks.

Think of it as a "three-strikes" NSAID.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote